← Back to patent-cliff list
CAS 24065-33-6
5-chlorothiophene-2-carboxylic acid
Codes: RIVA-015
Application context (from source-drug indications)
Pulmonary embolismRivaroxabanStrokeRivaroxabanCongenital heart defectRivaroxabanThrombosisRivaroxabanVenous thromboembolismRivaroxabanCoronary artery diseaseRivaroxaban
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Rivaroxaban | Tier A — Act now | 2026 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-(4-aminophenyl)morpholin-3-one→5-chlorothiophene-2-carbonyl chloride→5-chlorothiophene-2-carbaldehyde→5-chlorothiophene-2-carboxylic acid→(S)-3-aminopropane-1,2-diol hydrochloride→(S)-5-chloro-N-(2,3-dihydroxypropyl)thiophene-2-carboxamide→(S)-N-(3-bromo-2-hydroxypropyl)-5-chlorothiophene-2-carboxamide→(R)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Unibest Taizhou GMP-like Site | 5-Chlorothiophene-2-carboxylic acid Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.